Category: Speeches

  • Kevin Barron – 2016 Parliamentary Question to the Department of Health

    Kevin Barron – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Kevin Barron on 2016-01-13.

    To ask the Secretary of State for Health, what estimate he has made of the potential annual savings to the NHS through greater generic substitution compared to using their reference originator products; and what assessment he has made of the obstacles to implementing such a policy for (a) inhalers and biologics and (b) after complex products.

    George Freeman

    The Government has made no such assessments. England has one of the highest levels of generic prescribing in Europe. In 2014, the Health & Social Care Information Centre report Prescriptions Dispensed in the community: England 2004-14, shows that of all medicines dispensed in 2014, 84.1% were dispensed generically.

    Prescribers are ultimately responsible for their own prescribing decisions. We expect them to always satisfy themselves that the medicines they consider appropriate for their patients can be safely prescribed and that patients are adequately monitored.

  • Corri Wilson – 2016 Parliamentary Question to the HM Treasury

    Corri Wilson – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Corri Wilson on 2016-02-05.

    To ask Mr Chancellor of the Exchequer, what recent assessment he has made of the efficiency of HM Revenue and Customs in handling written correspondence from members of the public.

    Mr David Gauke

    Such a review has not been carried out recently. However, HM Revenue and Customs (HMRC) regularly publish general performance reports at Gov.uk. HMRC targets for post are to reply to 80% within 15 working days, 95% within 40 working days, and 90% accuracy.

  • Steven Paterson – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    Steven Paterson – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Steven Paterson on 2016-03-02.

    To ask the Secretary of State for Culture, Media and Sport, whether his Department has a communication’s strategy to tackle violent extremism.

    Mr Edward Vaizey

    The Counter-Extremism Strategy, published in October last year, set out government’s response to the threat posed by extremism. As part of that response, the Department is supporting the Home Office led communications strategy. This includes work with broadcasters and technology companies to counter extremist ideologies, and to disrupt those sharing extremist content in the media and online.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government for what reason NHS England intends to treat only a specified number of patients in 2016–17, as defined by recently published run rates for operational delivery networks services.

    Lord Prior of Brampton

    The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.

    NHS England is funding providers to double the number of patients treated and this number will ensure the National Health Service fully meets in 2016/17 the patient numbers NICE set out for progressive rollout of the treatments at the time it published its guidance.

    NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.

    In meeting the obligations of its Mandate, NHS England has set out a planning approach for hepatitis C that delivers access to NICE recommended treatment without disinvestment in other health services.

  • Julian Knight – 2016 Parliamentary Question to the Department for Work and Pensions

    Julian Knight – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Julian Knight on 2016-05-04.

    To ask the Secretary of State for Work and Pensions, what plans he has to extend the Pensions Wise service to people (a) between 20 and 40 and (b) between 40 and 50; and if he will make that service available to advise people on whether to invest in a lifetime ISA or under auto enrolment.

    Justin Tomlinson

    Pension Wise provides free and impartial guidance to those aged 50 and over with a defined contribution pension to help them understand their options.

    It was announced at the 2015 summer budget that the age for eligibility would be lowered to 50. Pension Wise has developed new content for 50 – 54 year olds to make the guidance appointments more relevant to their needs and this is now live.

    The government plans to restructure the delivery of public financial guidance to ensure that all consumers can access the help they need when they need it.

    Pension Wise does not give specific advice on products or provider recommendations. There are currently no plans for Pension Wise to provide guidance on lifetime ISAs or Automatic Enrolment.

  • John Redwood – 2016 Parliamentary Question to the Northern Ireland Office

    John Redwood – 2016 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by John Redwood on 2016-06-20.

    To ask the Secretary of State for Northern Ireland, which EU (a) legislative and (b) other proposals her Department is leading negotiations on for the Government in the Council of the EU.

    Mr Ben Wallace

    The Department is not responsible for leading any negotiations at the EU Council.

  • Lord Freyberg – 2016 Parliamentary Question to the Department of Health

    Lord Freyberg – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Freyberg on 2016-09-05.

    To ask Her Majesty’s Government what measures they intend to put in place to ensure that patients with radioiodine refractory differentiated thyroid cancer can receive all effective clinical treatments currently available through EU authorisation.

    Lord Prior of Brampton

    Changes to the process for evaluating cancer drugs were introduced at the end of July 2016 as part of the new arrangements for the Cancer Drugs Fund (CDF). Under the new arrangements, all new cancer drugs are expected to be referred to the National Institute for Health and Care Excellence (NICE) for evaluation through its technology appraisal programme. In some cases, NICE will recommend that the cancer drug is funded through the CDF, which enables further evaluation of its place in therapy. Drugs that have a European Union (EU) or United Kingdom marketing authorisation for radioiodine refractory differentiated thyroid cancer will therefore be reviewed under this process and if found to be clinically and cost effective will become established treatment within the National Health Service.

    The UK remains a member of the EU until Article 50 negotiations have concluded. EU law continues to apply and ongoing compliance with EU law is considered important in facilitating orderly transition, for negotiating purposes, and to offer certainty in the meantime. As long as the UK is subject to EU law, the present arrangements remain in place.

  • Henry Bellingham – 2016 Parliamentary Question to the Ministry of Defence

    Henry Bellingham – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Henry Bellingham on 2016-10-20.

    To ask the Secretary of State for Defence, if he will list the (a) names and (b) salaries of the 10 most senior officials in the Iraq Historical Allegations Team.

    Mike Penning

    In accordance with normal practice we only provide the names of officials at Senior Civil Service level and their military equivalents. The Iraq Historic Allegations Team’s most senior officials comprise a mix of civilian and military personnel as follows:

    Director, Mr Mark Warwick – Senior Civil Service Band 1, £63,000 – £117,000

    Royal Navy OF5 (Captain), £84,000 – £93,000

    Royal Navy Police OF4 (Commander), £70,000 – £81,000

    Royal Navy Police OF3 (Lieutenant Commander), £49,000 – £59,000

    Civil Service Band B1, £59,000 – £70,000

    2 x Civil Service Band C1, £37,000 – £42,000

    4 x Civil Service Band C2, 30,000 – £35,000

  • Luciana Berger – 2015 Parliamentary Question to the Department of Health

    Luciana Berger – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2015-11-09.

    To ask the Secretary of State for Health, what the (a) furthest and (b) average distance was which patients travelled to in-patient mother and baby units specialising in psychiatric care during the perinatal period in each of the last three years.

    Alistair Burt

    The information requested is not collected centrally.

  • Kirsten Oswald – 2015 Parliamentary Question to the HM Treasury

    Kirsten Oswald – 2015 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Kirsten Oswald on 2015-12-08.

    To ask Mr Chancellor of the Exchequer, if he will encourage the Financial Conduct Authority to bring its investigation into the Connaught Fund to an early conclusion; and if he will make a statement.

    Harriett Baldwin

    The FCA is an independent non-governmental body responsible for regulating and supervising the financial services industry within the framework of statutory objectives and duties agreed by Parliament. Although the Treasury is responsible for setting the legal framework, oversight of business practicesis a matter for the FCA Board.

    The Government appreciates the real difficulties and the serious implications the Connaught issue has had for investors and is following the situation closely.